Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease

Bindu D. Paul, Juan I. Sbodio, Risheng Xu, M. Scott Vandiver, Jiyoung Y. Cha, Adele M. Snowman, Solomon H. Snyder

Research output: Contribution to journalArticlepeer-review

Abstract

Huntington's disease is an autosomal dominant disease associated with a mutation in the gene encoding huntingtin (Htt) leading to expanded polyglutamine repeats of mutant Htt (mHtt) that elicit oxidative stress, neurotoxicity, and motor and behavioural changes. Huntington's disease is characterized by highly selective and profound damage to the corpus striatum, which regulates motor function. Striatal selectivity of Huntington's disease may reflect the striatally selective small G protein Rhes binding to mHtt and enhancing its neurotoxicity. Specific molecular mechanisms by which mHtt elicits neurodegeneration have been hard to determine. Here we show a major depletion of cystathionine γ -lyase (CSE), the biosynthetic enzyme for cysteine, in Huntington's disease tissues, which may mediate Huntington's disease pathophysiology. The defect occurs at the transcriptional level and seems to reflect influences of mHtt on specificity protein 1, a transcriptional activator for CSE. Consistent with the notion of loss of CSE as a pathogenic mechanism, supplementation with cysteine reverses abnormalities in cultures of Huntington's disease tissues and in intact mouse models of Huntington's disease, suggesting therapeutic potential.

Original languageEnglish (US)
Pages (from-to)96-100
Number of pages5
JournalNature
Volume508
Issue number7498
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease'. Together they form a unique fingerprint.

Cite this